View in EDS HTML Full Text PDF Full Text

Efficacy and safety of steroid-sparing strategy in the treatment of AIHA associated with KSHV/HHV-8 positive multicentric Castleman disease.

Saved in:
Bibliographic Details
Title: Efficacy and safety of steroid-sparing strategy in the treatment of AIHA associated with KSHV/HHV-8 positive multicentric Castleman disease.
Authors: Dieudonné Y; Department of Clinical Immunology and Internal Medicine National Reference Center for Systemic Autoimmune Diseases (RESO), CHU Strasbourg Strasbourg France.; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute Université Paris Cité Paris France., Gourguechon C; Department of Hematology Centre Hospitalo-Universitaire d'Amiens Amiens France., Stammler R; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute Université Paris Cité Paris France., Delestre F; Department of Internal Medicine, Hôpital Cochin Université Paris Cité Paris France., Sorin B; Department of Internal Medicine, Hôpital Cochin Université Paris Cité Paris France., Dunogué B; Department of Internal Medicine, Hôpital Cochin Université Paris Cité Paris France., Dumas G; Department of Intensive Care CHU Grenoble-Alpes Grenoble France., Fouquet G; Department of Hematology Centre Hospitalier Sud-Francilien Corbeil-Essonnes France., Ronchetti AM; Department of Hematology Centre Hospitalier Sud-Francilien Corbeil-Essonnes France., Paule R; Department of Internal Medicine Hôpital Foch Suresnes France., Meliani P; Department of Infectious and Tropical Diseases Centre Hospitalier de Mayotte Mamoudzou Mayotte., Pansu N; Department of Infectious and Tropical Diseases CHU Gui de Chauliac Montpellier France., Buzele R; Department of Infectious and Tropical Diseases General Hospital St-Brieuc France., Noel R; Department of Hematology Institut Paoli-Calmettes Marseille France., Fadlallah J; Clinical Immunology Department, Hôpital Saint Louis Université Paris Cité Paris France.; National Reference Center for Castleman Disease, Hôpital Saint Louis Université Paris Cité Paris France., Malphettes M; Clinical Immunology Department, Hôpital Saint Louis Université Paris Cité Paris France.; National Reference Center for Castleman Disease, Hôpital Saint Louis Université Paris Cité Paris France., Corvilain E; Clinical Immunology Department, Hôpital Saint Louis Université Paris Cité Paris France.; National Reference Center for Castleman Disease, Hôpital Saint Louis Université Paris Cité Paris France., Meignin V; National Reference Center for Castleman Disease, Hôpital Saint Louis Université Paris Cité Paris France.; Pathology Department, Hôpital Saint Louis, AP-HP Université Paris Cité Paris France., Guillaud C; Department d'Aval des Urgences, Mondor Hospital Université Paris-Est Créteil Créteil France., Dossier A; Department of Internal Medicine Bichat Hospital, AP-HP. Nord - Université Paris Cité Paris France., Dion J; Department of Clinical Immunology and Internal Medicine CHU Toulouse-Oncopole Toulouse France., Gérard L; Clinical Immunology Department, Hôpital Saint Louis Université Paris Cité Paris France.; National Reference Center for Castleman Disease, Hôpital Saint Louis Université Paris Cité Paris France., Oksenhendler E; Clinical Immunology Department, Hôpital Saint Louis Université Paris Cité Paris France.; National Reference Center for Castleman Disease, Hôpital Saint Louis Université Paris Cité Paris France., Galicier L; National Reference Center for Castleman Disease, Hôpital Saint Louis Université Paris Cité Paris France.; Department of Internal Medicine CHU La Timone Marseille France., Boutboul D; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute Université Paris Cité Paris France.; National Reference Center for Castleman Disease, Hôpital Saint Louis Université Paris Cité Paris France.; Hematology Department, Hôpital Cochin Université Paris Cité Paris France.
Source: HemaSphere [Hemasphere] 2026 Apr 08; Vol. 10 (4), pp. e70304. Date of Electronic Publication: 2026 Apr 08 (Print Publication: 2026).
Publication Type: Letter
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41959728
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and safety of steroid-sparing strategy in the treatment of AIHA associated with KSHV/HHV-8 positive multicentric Castleman disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dieudonné+Y%22">Dieudonné Y</searchLink>; Department of Clinical Immunology and Internal Medicine National Reference Center for Systemic Autoimmune Diseases (RESO), CHU Strasbourg Strasbourg France.; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute Université Paris Cité Paris France.<br /><searchLink fieldCode="AU" term="%22Gourguechon+C%22">Gourguechon C</searchLink>; Department of Hematology Centre Hospitalo-Universitaire d'Amiens Amiens France.<br /><searchLink fieldCode="AU" term="%22Stammler+R%22">Stammler R</searchLink>; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute Université Paris Cité Paris France.<br /><searchLink fieldCode="AU" term="%22Delestre+F%22">Delestre F</searchLink>; Department of Internal Medicine, Hôpital Cochin Université Paris Cité Paris France.<br /><searchLink fieldCode="AU" term="%22Sorin+B%22">Sorin B</searchLink>; Department of Internal Medicine, Hôpital Cochin Université Paris Cité Paris France.<br /><searchLink fieldCode="AU" term="%22Dunogué+B%22">Dunogué B</searchLink>; Department of Internal Medicine, Hôpital Cochin Université Paris Cité Paris France.<br /><searchLink fieldCode="AU" term="%22Dumas+G%22">Dumas G</searchLink>; Department of Intensive Care CHU Grenoble-Alpes Grenoble France.<br /><searchLink fieldCode="AU" term="%22Fouquet+G%22">Fouquet G</searchLink>; Department of Hematology Centre Hospitalier Sud-Francilien Corbeil-Essonnes France.<br /><searchLink fieldCode="AU" term="%22Ronchetti+AM%22">Ronchetti AM</searchLink>; Department of Hematology Centre Hospitalier Sud-Francilien Corbeil-Essonnes France.<br /><searchLink fieldCode="AU" term="%22Paule+R%22">Paule R</searchLink>; Department of Internal Medicine Hôpital Foch Suresnes France.<br /><searchLink fieldCode="AU" term="%22Meliani+P%22">Meliani P</searchLink>; Department of Infectious and Tropical Diseases Centre Hospitalier de Mayotte Mamoudzou Mayotte.<br /><searchLink fieldCode="AU" term="%22Pansu+N%22">Pansu N</searchLink>; Department of Infectious and Tropical Diseases CHU Gui de Chauliac Montpellier France.<br /><searchLink fieldCode="AU" term="%22Buzele+R%22">Buzele R</searchLink>; Department of Infectious and Tropical Diseases General Hospital St-Brieuc France.<br /><searchLink fieldCode="AU" term="%22Noel+R%22">Noel R</searchLink>; Department of Hematology Institut Paoli-Calmettes Marseille France.<br /><searchLink fieldCode="AU" term="%22Fadlallah+J%22">Fadlallah J</searchLink>; Clinical Immunology Department, Hôpital Saint Louis Université Paris Cité Paris France.; National Reference Center for Castleman Disease, Hôpital Saint Louis Université Paris Cité Paris France.<br /><searchLink fieldCode="AU" term="%22Malphettes+M%22">Malphettes M</searchLink>; Clinical Immunology Department, Hôpital Saint Louis Université Paris Cité Paris France.; National Reference Center for Castleman Disease, Hôpital Saint Louis Université Paris Cité Paris France.<br /><searchLink fieldCode="AU" term="%22Corvilain+E%22">Corvilain E</searchLink>; Clinical Immunology Department, Hôpital Saint Louis Université Paris Cité Paris France.; National Reference Center for Castleman Disease, Hôpital Saint Louis Université Paris Cité Paris France.<br /><searchLink fieldCode="AU" term="%22Meignin+V%22">Meignin V</searchLink>; National Reference Center for Castleman Disease, Hôpital Saint Louis Université Paris Cité Paris France.; Pathology Department, Hôpital Saint Louis, AP-HP Université Paris Cité Paris France.<br /><searchLink fieldCode="AU" term="%22Guillaud+C%22">Guillaud C</searchLink>; Department d'Aval des Urgences, Mondor Hospital Université Paris-Est Créteil Créteil France.<br /><searchLink fieldCode="AU" term="%22Dossier+A%22">Dossier A</searchLink>; Department of Internal Medicine Bichat Hospital, AP-HP. Nord - Université Paris Cité Paris France.<br /><searchLink fieldCode="AU" term="%22Dion+J%22">Dion J</searchLink>; Department of Clinical Immunology and Internal Medicine CHU Toulouse-Oncopole Toulouse France.<br /><searchLink fieldCode="AU" term="%22Gérard+L%22">Gérard L</searchLink>; Clinical Immunology Department, Hôpital Saint Louis Université Paris Cité Paris France.; National Reference Center for Castleman Disease, Hôpital Saint Louis Université Paris Cité Paris France.<br /><searchLink fieldCode="AU" term="%22Oksenhendler+E%22">Oksenhendler E</searchLink>; Clinical Immunology Department, Hôpital Saint Louis Université Paris Cité Paris France.; National Reference Center for Castleman Disease, Hôpital Saint Louis Université Paris Cité Paris France.<br /><searchLink fieldCode="AU" term="%22Galicier+L%22">Galicier L</searchLink>; National Reference Center for Castleman Disease, Hôpital Saint Louis Université Paris Cité Paris France.; Department of Internal Medicine CHU La Timone Marseille France.<br /><searchLink fieldCode="AU" term="%22Boutboul+D%22">Boutboul D</searchLink>; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute Université Paris Cité Paris France.; National Reference Center for Castleman Disease, Hôpital Saint Louis Université Paris Cité Paris France.; Hematology Department, Hôpital Cochin Université Paris Cité Paris France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101740619%22">HemaSphere</searchLink> [Hemasphere] 2026 Apr 08; Vol. 10 (4), pp. e70304. <i>Date of Electronic Publication: </i>2026 Apr 08 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101740619 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2572-9241 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225729241%22">25729241 </searchLink><i>NLM ISO Abbreviation: </i>Hemasphere <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41959728
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/hem3.70304
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70304
    Titles:
      – TitleFull: Efficacy and safety of steroid-sparing strategy in the treatment of AIHA associated with KSHV/HHV-8 positive multicentric Castleman disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dieudonné Y
      – PersonEntity:
          Name:
            NameFull: Gourguechon C
      – PersonEntity:
          Name:
            NameFull: Stammler R
      – PersonEntity:
          Name:
            NameFull: Delestre F
      – PersonEntity:
          Name:
            NameFull: Sorin B
      – PersonEntity:
          Name:
            NameFull: Dunogué B
      – PersonEntity:
          Name:
            NameFull: Dumas G
      – PersonEntity:
          Name:
            NameFull: Fouquet G
      – PersonEntity:
          Name:
            NameFull: Ronchetti AM
      – PersonEntity:
          Name:
            NameFull: Paule R
      – PersonEntity:
          Name:
            NameFull: Meliani P
      – PersonEntity:
          Name:
            NameFull: Pansu N
      – PersonEntity:
          Name:
            NameFull: Buzele R
      – PersonEntity:
          Name:
            NameFull: Noel R
      – PersonEntity:
          Name:
            NameFull: Fadlallah J
      – PersonEntity:
          Name:
            NameFull: Malphettes M
      – PersonEntity:
          Name:
            NameFull: Corvilain E
      – PersonEntity:
          Name:
            NameFull: Meignin V
      – PersonEntity:
          Name:
            NameFull: Guillaud C
      – PersonEntity:
          Name:
            NameFull: Dossier A
      – PersonEntity:
          Name:
            NameFull: Dion J
      – PersonEntity:
          Name:
            NameFull: Gérard L
      – PersonEntity:
          Name:
            NameFull: Oksenhendler E
      – PersonEntity:
          Name:
            NameFull: Galicier L
      – PersonEntity:
          Name:
            NameFull: Boutboul D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 04
              Text: 2026 Apr 08
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2572-9241
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: HemaSphere
              Type: main
ResultId 1